BSE filing, NSE: NAHARPOLY. Summary written from the filing by ALFA Finder's alert engine.
Nahar Poly Films Ltd: key numbers
- Share price
- ₹223.99
- Market cap
- ₹550.8 Cr
- Revenue (annual)
- ₹704.2 Cr
- Net profit (annual)
- ₹78.84 Cr
- P/E (TTM)
- 7.6×Sector 52.0×
- Promoter holding
- 72.93%+0.42% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Nahar Poly Films Ltd
All →Nahar Poly Films Board Meeting Date
Nahar Polyfilms scheduled a board meeting for October 30, 2026, to approve standalone and consolidated financial results for the quarter ended September 30, 2026.
Nahar Poly Films Management Change
Nahar Poly Films Ltd shareholders approved the re-appointment of four Independent Directors: Dr. Anchal Kumar Jain, Dr. Roshan Lal Behl, Dr. Prem Lata Singla, and Dr. Rajan Dhir.
Nahar Poly Films Annual General Meeting
Nahar Poly Films Ltd held its 38th AGM on September 25, 2026, where shareholders adopted financial statements and approved the final dividend and director appointments.
Nahar Poly Films Annual Report
The company has filed its Annual Report for the financial year 2025-26, which includes the notice for the 38th Annual General Meeting scheduled for September 25, 2026.
Nahar Poly Films Other Announcement
Nahar Poly Films Ltd has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. This report provides disclosure on the company's ESG performance.
Nahar Poly Films Annual General Meeting
Nahar Poly Films Ltd. issued a notice for its 38th Annual General Meeting on September 25, 2026. The meeting covers financial adoption, dividend declaration, and director appointments.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.